How healthy is the health budget of < em > Amrit Kaal < /em > : 2023-24?
J Family Med Prim Care. 2024 Jan;13(1):5-9. doi: 10.4103/jfmpc.jfmpc_398_23. Epub 2024 Feb 8.ABSTRACTPolitical will is the key to public health policy-making and a major driving force for the attainment of Universal Health Coverage (UHC) in any nation. To achieve UHC, the Indian government laid down National Health Policy in 1983 and updated it in 2002 and recently in 2017. This recent policy emphasized increasing healthcare spending and economic growth. In the current budget, there is an increment in the share of GDP of 0.34% from the previous year's allocation, but still staggering for the envisaged 2.5% to achieve UHC. ...
Source: Primary Care - March 14, 2024 Category: Primary Care Authors: Madan M Majhi Anshita Mishra Suneela Garg Raman Kumar Source Type: research
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease
Bone Marrow Transplantation, Published online: 14 March 2024; doi:10.1038/s41409-024-02257-8Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease (Source: Bone Marrow Transplantation)
Source: Bone Marrow Transplantation - March 14, 2024 Category: Hematology Authors: Sabine F ürst Emmanuelle Bernit Faezeh Legrand Angela Granata Samia Harbi Raynier Devillier Valerio Maisano Benjamin Bouchacourt Thomas Pagliardini Djamel Mokart Claude Lemari é Boris Calmels Christophe Picard Agn ès Basire Borje S. Andersson Didier Bl Source Type: research
Maximizing longevity: erythropoietin's impact on sickle cell anaemia survival rates
In conclusion, while the application of EPO in SCA treatment holds promise, additional research is indispensable to comprehend its precise role, optimize dosing strategies, and ensure safety, thereby paving the way for enhanced life expectancy and improved outcomes for individuals living with SCA.PMID:38463100 | PMC:PMC10923353 | DOI:10.1097/MS9.0000000000001763 (Source: Annals of Medicine)
Source: Annals of Medicine - March 11, 2024 Category: Internal Medicine Authors: Emmanuel Ifeanyi Obeagu Source Type: research
Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post-2016 CDC Guideline
CONCLUSIONS AND RELEVANCE: This retrospective cohort study showed that the 2016 CDC guideline may have had unintended negative outcomes on the patient population living with SCD.PMID:38466269 | DOI:10.1001/jamainternmed.2023.8538 (Source: Cancer Control)
Source: Cancer Control - March 11, 2024 Category: Cancer & Oncology Authors: Hyeun Ah Kang Bofei Wang Jamie C Barner Kenneth I Ataga Robert C Mignacca Alicia Chang Yahan Zhang Source Type: research
Maximizing longevity: erythropoietin's impact on sickle cell anaemia survival rates
In conclusion, while the application of EPO in SCA treatment holds promise, additional research is indispensable to comprehend its precise role, optimize dosing strategies, and ensure safety, thereby paving the way for enhanced life expectancy and improved outcomes for individuals living with SCA.PMID:38463100 | PMC:PMC10923353 | DOI:10.1097/MS9.0000000000001763 (Source: Annals of Medicine)
Source: Annals of Medicine - March 11, 2024 Category: Internal Medicine Authors: Emmanuel Ifeanyi Obeagu Source Type: research
Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post –2016 CDC Guideline
This retrospective cohort study examines changes in opioid prescribing patterns and health outcomes among patients with sickle cell disease before and after the release of the 2016 US Centers for Disease Control and Prevention (CDC) opioid. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - March 11, 2024 Category: Internal Medicine Source Type: research
Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units
CONCLUSION: The transfusion protocol is established to prevent immunological reactions due to disparities in blood group antigens between donors and SCD recipients. However, the units of African ancestry donors, which allowed the best compatibility, displayed a high rate of G6PD deficiency. The storage and recovery impact of this deficiency must be evaluated.PMID:38462030 | DOI:10.1016/j.tracli.2024.03.002 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - March 10, 2024 Category: Hematology Authors: Morgane Le Gallo St éphane Moutereau M élanie Gentil France Pirenne Source Type: research
Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units
CONCLUSION: The transfusion protocol is established to prevent immunological reactions due to disparities in blood group antigens between donors and SCD recipients. However, the units of African ancestry donors, which allowed the best compatibility, displayed a high rate of G6PD deficiency. The storage and recovery impact of this deficiency must be evaluated.PMID:38462030 | DOI:10.1016/j.tracli.2024.03.002 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - March 10, 2024 Category: Hematology Authors: Morgane Le Gallo St éphane Moutereau M élanie Gentil France Pirenne Source Type: research
Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units
CONCLUSION: The transfusion protocol is established to prevent immunological reactions due to disparities in blood group antigens between donors and SCD recipients. However, the units of African ancestry donors, which allowed the best compatibility, displayed a high rate of G6PD deficiency. The storage and recovery impact of this deficiency must be evaluated.PMID:38462030 | DOI:10.1016/j.tracli.2024.03.002 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - March 10, 2024 Category: Hematology Authors: Morgane Le Gallo St éphane Moutereau M élanie Gentil France Pirenne Source Type: research
Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units
CONCLUSION: The transfusion protocol is established to prevent immunological reactions due to disparities in blood group antigens between donors and SCD recipients. However, the units of African ancestry donors, which allowed the best compatibility, displayed a high rate of G6PD deficiency. The storage and recovery impact of this deficiency must be evaluated.PMID:38462030 | DOI:10.1016/j.tracli.2024.03.002 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - March 10, 2024 Category: Hematology Authors: Morgane Le Gallo St éphane Moutereau M élanie Gentil France Pirenne Source Type: research
Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units
CONCLUSION: The transfusion protocol is established to prevent immunological reactions due to disparities in blood group antigens between donors and SCD recipients. However, the units of African ancestry donors, which allowed the best compatibility, displayed a high rate of G6PD deficiency. The storage and recovery impact of this deficiency must be evaluated.PMID:38462030 | DOI:10.1016/j.tracli.2024.03.002 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - March 10, 2024 Category: Hematology Authors: Morgane Le Gallo St éphane Moutereau M élanie Gentil France Pirenne Source Type: research
Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units
CONCLUSION: The transfusion protocol is established to prevent immunological reactions due to disparities in blood group antigens between donors and SCD recipients. However, the units of African ancestry donors, which allowed the best compatibility, displayed a high rate of G6PD deficiency. The storage and recovery impact of this deficiency must be evaluated.PMID:38462030 | DOI:10.1016/j.tracli.2024.03.002 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - March 10, 2024 Category: Hematology Authors: Morgane Le Gallo St éphane Moutereau M élanie Gentil France Pirenne Source Type: research
Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units
CONCLUSION: The transfusion protocol is established to prevent immunological reactions due to disparities in blood group antigens between donors and SCD recipients. However, the units of African ancestry donors, which allowed the best compatibility, displayed a high rate of G6PD deficiency. The storage and recovery impact of this deficiency must be evaluated.PMID:38462030 | DOI:10.1016/j.tracli.2024.03.002 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - March 10, 2024 Category: Hematology Authors: Morgane Le Gallo St éphane Moutereau M élanie Gentil France Pirenne Source Type: research
Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units
CONCLUSION: The transfusion protocol is established to prevent immunological reactions due to disparities in blood group antigens between donors and SCD recipients. However, the units of African ancestry donors, which allowed the best compatibility, displayed a high rate of G6PD deficiency. The storage and recovery impact of this deficiency must be evaluated.PMID:38462030 | DOI:10.1016/j.tracli.2024.03.002 (Source: Transfusion Clinique et Biologique)
Source: Transfusion Clinique et Biologique - March 10, 2024 Category: Hematology Authors: Morgane Le Gallo St éphane Moutereau M élanie Gentil France Pirenne Source Type: research
Splenic Subcapsular Hematoma from Commercial Air Travel: Case Report of a Unique Incident of Altitude-Associated Splenic Syndrome
We present a case of a 41-year-old man with a history of SCT who developed severe epigastric pain and nearly lost consciousness while traveling on a commercial airplane. His twin brother, who also has SCT, had a similar episode in the past and required a splenectomy. A splenic subcapsular hematoma was found in a computed tomography scan of the abdomen and pelvis with intravenous contrast. He was admitted and managed conservatively until his symptoms resolved. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Though SCT is prevalent in our population, the complications that can arise, such as altitude-associated splenic ...
Source: Pain Physician - March 9, 2024 Category: Anesthesiology Authors: Lauren Santucci Anthony Almeida Source Type: research
